Zanaflex is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Acorda Therapeutics, Inc.. The primary component is Tizanidine Hydrochloride.
| Product ID | 10144-602_7897aa33-13b7-f553-e053-2a91aa0a2c3f |
| NDC | 10144-602 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Zanaflex |
| Generic Name | Tizanidine Hydrochloride |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2005-04-04 |
| Marketing End Date | 2019-07-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021447 |
| Labeler Name | Acorda Therapeutics, Inc. |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2017-04-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021447 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-04-04 |
| Marketing End Date | 2019-07-31 |
| Ingredient | Strength |
|---|---|
| TIZANIDINE HYDROCHLORIDE | 2 mg/1 |
| SPL SET ID: | 413ee468-c7e8-4283-8e2b-b573dcc1f607 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10144-594 | Zanaflex | tizanidine hydrochloride |
| 10144-602 | Zanaflex | tizanidine hydrochloride |
| 10144-604 | Zanaflex | tizanidine hydrochloride |
| 10144-606 | Zanaflex | tizanidine hydrochloride |
| 21695-373 | Zanaflex | tizanidine hydrochloride |
| 70515-594 | Zanaflex | Zanaflex |
| 70515-604 | Zanaflex | Zanaflex |
| 70515-602 | Zanaflex | Zanaflex |
| 70515-606 | Zanaflex | Zanaflex |
| 55289-612 | Zanaflex | Zanaflex |
| 80425-0022 | Zanaflex | Zanaflex |
| 80425-0024 | Zanaflex | Zanaflex |
| 80425-0090 | Zanaflex | Zanaflex |
| 80425-0023 | Zanaflex | Zanaflex |
| 0185-0034 | tizanidine hydrochloride | tizanidine hydrochloride |
| 0185-4400 | tizanidine hydrochloride | tizanidine hydrochloride |
| 0591-2788 | tizanidine hydrochloride | tizanidine hydrochloride |
| 0591-2789 | tizanidine hydrochloride | tizanidine hydrochloride |
| 0591-2790 | tizanidine hydrochloride | tizanidine hydrochloride |
| 21695-126 | TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE |
| 21695-127 | TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE |
| 35356-662 | TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE |
| 42291-810 | Tizanidine Hydrochloride | Tizanidine Hydrochloride |
| 42291-811 | Tizanidine Hydrochloride | Tizanidine Hydrochloride |
| 42291-812 | Tizanidine Hydrochloride | Tizanidine Hydrochloride |
| 45865-954 | Tizanidine Hydrochloride | Tizanidine Hydrochloride |
| 46708-491 | Tizanidine Hydrochloride | Tizanidine Hydrochloride |
| 46708-492 | Tizanidine Hydrochloride | Tizanidine Hydrochloride |
| 46708-493 | Tizanidine Hydrochloride | Tizanidine Hydrochloride |
| 49884-611 | tizanidine hydrochloride | tizanidine hydrochloride |
| 49884-719 | tizanidine hydrochloride | tizanidine hydrochloride |
| 49884-765 | tizanidine hydrochloride | tizanidine hydrochloride |
| 49999-347 | Tizanidine Hydrochloride | Tizanidine Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZANAFLEX 75186534 2383531 Live/Registered |
COVIS PHARMA B.V. 1996-10-15 |
![]() ZANAFLEX 74400930 1906277 Dead/Cancelled |
ELAN PHARMACEUTICALS, INC. 1993-06-09 |